Three cardiovascular risk scores: why Framingham overestimates in low-incidence populations, what REGICOR is and why SCORE2 is the current European standard.
SCORE2 and REGICOR are European and Spanish tools. In the United States, the 2018 AHA/ACC cholesterol guideline keeps the 2013 Pooled Cohort Equations as the standard way to estimate the 10-year risk of atherosclerotic cardiovascular disease in adults aged 40 to 75, and these equations are known to overestimate risk in some populations. The scores below are not interchangeable with them.
The Framingham equation was the first to estimate cardiovascular risk at 10 years from factors such as age, sex, smoking, cholesterol and blood pressure. Its problem in southern Europe is that it overestimates risk in low-incidence populations such as the Mediterranean one.
REGICOR is the Spanish adaptation of Framingham: it recalibrates the equation with data from the Spanish population (the Girona registry) so as not to overestimate. For years it was the one recommended in Spain.
SCORE2 (and SCORE2-OP in older people) is the current European tool. It estimates the 10-year risk of fatal and non-fatal cardiovascular events (an improvement over the original SCORE, which measured only mortality), by risk region.
In Europe the current guideline recommends SCORE2. In Spain, REGICOR remains a validated option. What should not be used without more is the "original" Framingham, because it overestimates. For diabetes risk, the analogous score is the FINDRISC test.
Framingham overestimates in low-incidence populations; REGICOR is its Spanish calibration; and SCORE2 is the current European standard, which includes fatal and non-fatal events. These are primary prevention scores (in a patient with established disease, the risk is already high and is not calculated).
← All articles · Medical score calculators · Versión en español